S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

PHASE1CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

September 30, 2006

Study Completion Date

December 31, 2007

Conditions
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

BMS-247550

BMS-247550 as a 3-hour infusion on Day 1 of a three-week cycle

Trial Locations (23)

44106

Case Comprehensive Cancer Center, Cleveland

44131

Community Oncology Group at Cleveland Clinic Cancer Center, Independence

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

44691

Cleveland Clinic - Wooster, Wooster

60153

Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood

78234

Brooke Army Medical Center, Fort Sam Houston

78236

Wilford Hall Medical Center, Lackland Air Force Base

95817

University of California Davis Cancer Center, Sacramento

98104

Fred Hutchinson Cancer Research Center, Seattle

Harborview Medical Center, Seattle

98225

St. Joseph Hospital Community Cancer Center, Bellingham

98273

Skagit Valley Hospital Cancer Care Center, Mount Vernon

98284

North Puget Oncology at United General Hospital, Sedro-Woolley

98310

Olympic Hematology and Oncology, Bremerton

99202

Cancer Care Northwest - Spokane South, Spokane

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

90089-9181

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

66160-7357

Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City

78229-3900

University of Texas Health Science Center at San Antonio, San Antonio

98104-1387

Group Health Central Hospital, Seattle

98122-4307

Swedish Cancer Institute at Swedish Medical Center - First Hill Campus, Seattle

98195-6043

University Cancer Center at University of Washington Medical Center, Seattle

98801-2028

Wenatchee Valley Medical Center, Wenatchee

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

SWOG Cancer Research Network

NETWORK

NCT00049400 - S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction | Biotech Hunter | Biotech Hunter